Michael Daneshvar
Overview
Explore the profile of Michael Daneshvar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kinnaird A, Yerram N, OConnor L, Brisbane W, Sharma V, Chuang R, et al.
J Urol
. 2021 Dec;
207(4):823-831.
PMID: 34854746
Purpose: The underlying premise of prostate cancer active surveillance (AS) is that cancers likely to metastasize will be recognized and eliminated before cancer-related disease can ensue. Our study was designed...
12.
OConnor L, Ramedani S, Daneshvar M, George A, Abreu A, Cacciamani G, et al.
Asian J Urol
. 2021 Nov;
8(4):354-361.
PMID: 34765443
Objective: To summarize the recent literature discussing focal therapy for localized prostate cancer. Methods: A thorough literature review was performed using PubMed to identify recent studies involving focal therapy for...
13.
Bratslavsky G, Mendhiratta N, Daneshvar M, Brugarolas J, Ball M, Metwalli A, et al.
Cancer
. 2021 Aug;
127(21):3957-3966.
PMID: 34343338
Background: Although renal cell carcinoma (RCC) is believed to have a strong hereditary component, there is a paucity of published guidelines for genetic risk assessment. A panel of experts was...
14.
Leong J, Pinkhasov R, Chandrasekar T, Shapiro O, Daneshvar M, Jacob J, et al.
Eur Urol Focus
. 2021 Aug;
8(5):1125-1132.
PMID: 34332951
Background: Patients with disabilities represent a unique minority population. The incidence of prostate-specific antigen (PSA) testing among this population is unknown. Objective: To compare PSA testing rates and associated predictors...
15.
Bratslavsky G, Sokol E, Daneshvar M, Necchi A, Shapiro O, Jacob J, et al.
Cancers (Basel)
. 2021 Jul;
13(13).
PMID: 34282751
Patients with clinically advanced paragangliomas (CA-Para) and pheochromocytomas (CA-Pheo) have limited surgical or systemic treatments. We used comprehensive genomic profiling (CGP) to compare genomic alterations (GA) in CA-Para and CA-Pheo...
16.
Webster B, Rompre-Brodeur A, Daneshvar M, Pahwa R, Srinivasan R
Curr Probl Cancer
. 2021 Jul;
45(4):100773.
PMID: 34261604
Renal cell carcinoma incidence is rising worldwide with increasing subtype stratification by the World Health Organization. Each subtype has unique genetic alterations, cell biology changes and clinical findings. Such genetic...
17.
Khondakar N, Owens-Walton J, Daneshvar M, Williams C, OConnor L, Yerram N, et al.
Clin Adv Hematol Oncol
. 2021 Jul;
19(7):460-467.
PMID: 34236345
Oligometastatic prostate cancer is a subtype of metastatic disease that generally is defined by the presence of 5 or fewer metastatic lesions. Metastatic prostate cancer currently is treated with androgen...
18.
Dispagna M, Daneshvar M, Bratslavsky G
Int Braz J Urol
. 2021 Mar;
47(5):935-942.
PMID: 33650834
Purpose: To review the current literature regarding variant (non-clear) histology of renal cell carcinoma (RCC) and the clinical management of these renal tumors. Material And Methods: A PubMed database search...
19.
Williams C, Daneshvar M, Pinto P
Curr Opin Oncol
. 2021 Feb;
33(3):244-251.
PMID: 33606404
Purpose Of Review: To explore the recent advances and utility of multiparametric magnetic resonance imaging (mpMRI) in the diagnosis and risk-stratification of prostate cancer. Recent Findings: Low-risk, clinically insignificant prostate...
20.
DiLizia E, Ahdoot M, Daneshvar M, Gomella P, Yerram N, Pinto P
Urol Case Rep
. 2020 Oct;
34:101445.
PMID: 33102128
Definitive treatment for local prostate cancer recurrence remains controversial. Early recurrences are often from positive surgical margins or nodal metastases, however other explanations should be considered. We present a case...